Innovation Archives

BaseLaunch is top European accelerator

Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization BaselArea.swiss, is among the leading accelerators of its kind…

Jérémie Meyer05.21.2019

Pfizer acquires Basel-based Therachon

U.S. pharmaceutical company Pfizer is acquiring Basel biotech Therachon for US$ 340 million. Additional payments of US$ 470 million may…

Jérémie Meyer05.09.2019

Switzerland excels with biotech start-ups

According to an article in the journal “Nature”, Switzerland is the European leader with its biotech start-up ecosystem. Based on…

Jérémie Meyer05.06.2019

33 recently arrived companies create hundreds of jobs

The efforts of BaselArea.swiss proved extremely successful in 2018. 33 companies – seven more than in the previous year –…

Jérémie Meyer03.28.2019

Anaveon raises CHF 35 million

Anaveon, an immuno-oncology biotech, has successfully concluded a Series A financing round led by Syncona, a UK Life Sciences fund,…

Jérémie Meyer02.26.2019

First semester starts well for FHNW Campus Muttenz

The semester has got off to a successful start at FHNW University of Applied Sciences and Arts Northwestern Switzerland’s new…

Jérémie Meyer09.20.2018

BaseLaunch’s second round – 10 projects enter Phase I

The BaseLaunch Accelerator, managed and operated by BaselArea.swiss, started on 14 September 2018 with ten projects entering Phase I. Over…

Jérémie Meyer09.18.2018

Meet the BaseLaunch Startups

Six of the BaseLaunch startups recently started Phase II. They received either grants up to 250,000 Swiss francs or gained…

Jérémie Meyer03.11.2018

BioMedPartners closes new venture capital fund

Basel-based venture capitalist firm BioMedPartners has closed its new venture capital fund BioMedInvest III at 100 million Swiss francs. The…

Jérémie Meyer03.06.2018

BaseLaunch up to a solid Phase II start

BaseLaunch has officially started Phase II of its accelerator program, and four startups are receiving grants ranging from 120,000 to…

Jérémie Meyer01.30.2018